Earnings Feed
Start Free
Theriva Biologics, Inc.·4

Jan 3, 6:04 AM ET

SHALLCROSS STEVEN A 4

4 · Theriva Biologics, Inc. · Filed Jan 3, 2023

Insider Transaction Report

Form 4
Period: 2022-12-29
Theriva Biologics, Inc.TOVX
SHALLCROSS STEVEN A
DirectorCEO and CFO
Transactions
  • Purchase

    Common Stock

    2022-12-29$0.44/sh+100,000$43,700→ 110,000 total

Documents

1 file
  • 4
    tm2233803d1_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT